Status | Study |
Recruiting |
Study Name: Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Condition: Adult Germ Cell Tumor Childhood Extracranial Germ Cell Tumor Date: 2017-02-14 Interventions: Other: Best Practice Undergo o |
Recruiting |
Study Name: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condition: Germ Cell Tumor Teratoma Choriocarcinoma Date: 2015-02-20 Interventions: Drug: paclitaxel IV |
Recruiting |
Study Name: A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent Condition: Extra Cranial Non Seminomateous Malignant Germ Cell Tumour Date: 2014-03-27 Interventions: Drug: Velbe-Bleomycin-Cisplatin |
Completed |
Study Name: Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression Condition: Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Ova Date: 2011-09-09 Interventions: Genetic: DNA methylation analysis Genetic: |
Completed |
Study Name: PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Condition: Brain and Central Nervous System Tumors Date: 2010-07-07 Interventions: Drug: VEGF inhibitor PTC299 This is a dose escalation study. Study participants will receive .6 or 1.2 m |
Active, not recruiting |
Study Name: Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Condition: Hepatoblastoma Previously Treated Childhood Rhabdomyosarcoma Date: 2010-06-30 Interventions: Drug: Alisertib Given orally |
Terminated |
Study Name: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Condition: Cancer Date: 2010-05-26 Interventions: Drug: cyproheptadine hydrochloride |
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Choriocarcinoma Date: 2009-10-10 Interventions: Drug: vorinostat Given orally |
Recruiting |
Study Name: Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Condition: Adult Central Nervous System Germ Cell Tumor Adult Ependymoblastoma Date: 2009-09-23 Interventions: Drug: Carboplatin Given IA |
Recruiting |
Study Name: Collecting and Storing Tissue From Young Patients With Cancer Condition: Cancer Date: 2009-05-09 Interventions: Genetic: DNA analysis Genetic: reverse tra |